Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q2- Text added to 2022 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
New words:
Accutar, apelisib, beneficiary, Borestrant, CDK, central, climate, conflict, conventional, coupled, differentiated, donut, downturn, economy, enhanced, EnhancedBio, Fast, geopolitical, hole, imlunestrant, IRA, led, likewise, macroeconomic, Menarini, outpace, Pharma, qualification, recession, Russia, stability, Sun, TTC, Ukraine, unmet, weak
Valuein 2022 Q2 filing- Value in 2022 Q3 filing
Original filings
Filing view